SERUM FERRITIN, SEX-HORMONES, AND CARDIOVASCULAR RISK-FACTORS IN HEALTHY WOMEN

被引:55
作者
BERGE, LN
BONAA, KH
NORDOY, A
机构
[1] UNIV TROMSO, INST CLIN MED, DEPT MED, TROMSO, NORWAY
[2] UNIV TROMSO, INST COMMUNITY MED, TROMSO, NORWAY
来源
ARTERIOSCLEROSIS AND THROMBOSIS | 1994年 / 14卷 / 06期
关键词
CHOLESTEROL; FERRITIN; MENOPAUSE; WOMEN;
D O I
10.1161/01.ATV.14.6.857
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The protective effect of endogenous sex hormones is commonly believed to explain the gender gap in the risk of coronary heart disease and the diminished protection in women when menopause occurs. Recent reports indicate that iron overload, due to cessation of menstrual bleeding, may be an important factor. We therefore investigated iron stores by serum ferritin measurements in healthy premenopausal (n=113) and postmenopausal (n=46) women. Ferritin levels were higher in postmenopausal than in premenopausal women, both in blood donors (43.4 versus 23.1 mu g/L, P<.001) and in nondonors (71.7 versus 32.8 mu g/L, P<.001). Serum ferritin was positively correlated with age (r=.36, P<.001). After age adjustment, serum ferritin was positively correlated with hemoglobin, hematocrit, serum total cholesterol, and low-density lipoprotein (LDL) cholesterol. Total cholesterol was correlated with age (r=.66, P<.001), as were LDL cholesterol (r=.60, P<.01) and high-density lipoprotein cholesterol (r=.32, P<.01). Neither ferritin nor serum lipids were directly associated with female sex hormone levels. The mutual relation between ferritin, hemoglobin, and hematocrit probably only indicates their usefulness as measures of body iron. The parallel rise in serum ferritin, total cholesterol, and LDL cholesterol might contribute to the increased risk of coronary heart disease among postmenopausal women.
引用
收藏
页码:857 / 861
页数:5
相关论文
共 30 条
  • [1] THE BLEEDING-TIME IN WOMEN - AN INFLUENCE OF THE SEX-HORMONES
    BERGE, LN
    LYNGMO, V
    SVENSSON, B
    NORDOY, A
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1993, 72 (06) : 423 - 427
  • [2] MENOPAUSE-RELATED CHANGES IN LIPOPROTEINS AND SOME OTHER CARDIOVASCULAR RISK-FACTORS
    BONITHONKOPP, C
    SCARABIN, PY
    DARNE, B
    MALMEJAC, A
    GUIZE, L
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1990, 19 (01) : 42 - 48
  • [3] BURSTEIN M, 1970, J LIPID RES, V11, P583
  • [4] BUSH T, 1984, AM J EPIDEMIOL, V120, P489
  • [5] QUANTITATIVE AND QUALITATIVE SERUM LIPOPROTEIN ANALYSIS .1. STUDIES IN HEALTHY MEN AND WOMEN
    CARLSON, LA
    ERICSSON, M
    [J]. ATHEROSCLEROSIS, 1975, 21 (03) : 417 - 433
  • [6] CARTER JM, 1991, MED LAB SCI, V48, P134
  • [7] CASTELLI WP, 1988, AM J OBSTET GYNECOL, V158, P1553, DOI 10.1016/0002-9378(88)90189-5
  • [8] A PROSPECTIVE-STUDY OF OBESITY, LIPIDS, APOLIPOPROTEINS AND ISCHEMIC-HEART-DISEASE IN WOMEN
    COLEMAN, MP
    KEY, TJA
    WANG, DY
    HERMON, C
    FENTIMAN, IS
    ALLEN, DS
    JARVIS, M
    PIKE, MC
    SANDERS, TAB
    [J]. ATHEROSCLEROSIS, 1992, 92 (2-3) : 177 - 185
  • [9] THE EFFECTS OF AGE, BODY-WEIGHT AND FAMILY RELATIONSHIPS ON PLASMA-LIPOPROTEINS AND LIPIDS IN MEN, WOMEN AND CHILDREN OF RANDOMLY SELECTED FAMILIES
    CONNOR, SL
    CONNOR, WE
    SEXTON, G
    CALVIN, L
    BACON, S
    [J]. CIRCULATION, 1982, 65 (07) : 1290 - 1298
  • [10] COOK JD, 1976, BLOOD, V48, P449